GENUS PHARMACEUTICALS HOLDINGS LIMITED
Get an alert when GENUS PHARMACEUTICALS HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-04 (in 4mo)
Last made up 2025-08-21
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£15M
+10.6% vs 2023
Employees
2
0% vs 2023
Profit before tax
£14M
+45.2% vs 2023
Name history
Renamed 3 times since incorporation
- GENUS PHARMACEUTICALS HOLDINGS LIMITED 2004-06-30 → present
- SCHEIN PHARMACEUTICAL HOLDINGS UK LIMITED 1999-09-10 → 2004-06-30
- SCHEIN PHARMACEUTICAL UK LIMITED 1999-01-15 → 1999-09-10
- FIMTON LIMITED 1998-08-21 → 1999-01-15
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £1,877,000 | £8,557,000 | |
| Operating profit | £609,000 | £1,950,000 | |
| Profit before tax | £9,609,000 | £13,950,000 | |
| Net profit | £9,466,000 | £13,463,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £13,861,000 | £15,324,000 | |
| Net assets | £13,861,000 | £15,324,000 | |
| Equity | £13,861,000 | £15,324,000 | |
| Average employees | 2 | 2 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 32.4% | 22.8% | |
| Net margin | 504.3% | 157.3% | |
| Return on capital employed | 4.4% | 12.7% | |
| Current ratio | 0.24x | 0.28x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- GENUS PHARMACEUTICALS HOLDINGS LIMITED · parent
- Genus Pharmaceuticals Limited 100%
- Britannia Pharmaceuticals Limited 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 34 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| COLLETT, James David | Director | 2023-09-01 | Oct 1975 | British |
| SHAW, Craig Richard | Director | 2025-11-03 | Jan 1977 | British |
Show 34 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ADAMS, Geoffrey Martin | Secretary | 2016-05-01 | 2018-04-06 |
| ALPIN, Janet | Secretary | 2015-06-01 | 2016-05-01 |
| BLYTHE, Edwin Charles | Secretary | 2018-04-06 | 2023-01-31 |
| FEVERMAN, Paul | Secretary | 1999-10-15 | 2000-08-08 |
| FUNSTEN, Robert C | Secretary | 2000-12-07 | 2002-05-10 |
| GORE-STRACHAN, Evelyn | Secretary | 2014-06-30 | 2015-06-01 |
| HANLON, James | Secretary | 2006-04-05 | 2006-12-13 |
| HEYWOOD, Kathryn Maria | Secretary | 2023-01-31 | 2023-01-31 |
| SALMOND, Hamish George | Secretary | 1999-10-15 | 2004-06-04 |
| WATERS, Gary | Secretary | 1998-08-27 | 1999-10-15 |
| WRIGHT, Philip John | Secretary | 2006-12-13 | 2014-06-30 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Secretary | 1998-08-21 | 1998-08-27 |
| ADAMS, Geoffrey Martin | Director | 2015-06-01 | 2018-04-06 |
| ASHRAFI, Dariush | Director | 1998-08-27 | 2000-08-08 |
| BALLARD, Peter Gavin | Director | 2004-06-22 | 2013-10-15 |
| BLYTHE, Edwin Charles | Director | 2022-10-01 | 2023-01-31 |
| BRIERLEY, Charles Ashley | Director | 2018-12-31 | 2019-12-02 |
| CHAO, Allen Yuten | Director | 2000-12-07 | 2003-03-10 |
| DARROCH, Colin | Director | 1999-10-15 | 2001-03-16 |
| GEORGE, Dieno | Director | 2017-10-27 | 2018-12-31 |
| HANLON, James Anthony | Director | 2003-03-04 | 2010-05-17 |
| HEYWOOD, Kathryn Maria | Director | 2023-01-31 | 2023-09-01 |
| NIEMANN, Peter, Dipl Ing | Director | 2003-03-04 | 2005-04-21 |
| O RIORDAN, Rory Walter | Director | 2003-03-04 | 2005-04-21 |
| O' RIORDAN, Rory | Director | 2005-12-13 | 2010-05-17 |
| SCARLETT-SMITH, Roger Lidderdale | Director | 2019-12-02 | 2022-10-01 |
| SLEGERS, Luc Maurice Godelieva | Director | 2005-12-13 | 2017-10-31 |
| SPERBER, Martin | Director | 1999-10-15 | 2000-08-08 |
| STEPHENSON, Nigel David | Director | 2023-08-01 | 2025-07-31 |
| SYDOW, Volker | Director | 2025-06-17 | 2025-11-03 |
| WATERS, Gary | Director | 1998-08-27 | 2001-03-31 |
| WRIGHT, Philip John | Director | 2009-04-17 | 2010-05-17 |
| COMBINED NOMINEES LIMITED | Corporate Nominee Director | 1998-08-21 | 1998-08-27 |
| COMBINED SECRETARIAL SERVICES LIMITED | Corporate Nominee Director | 1998-08-21 | 1998-08-27 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Stada Uk Holdings Ltd | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-06-30 | Active |
Filing timeline
Last 20 of 156 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-04 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-08-07 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-08-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-20 | AP01 | officers | Appoint person director company with name date | |
| 2025-06-04 | AA | accounts | Accounts with accounts type full | |
| 2025-05-08 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-03-12 | CH01 | officers | Change person director company with change date | |
| 2025-01-15 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-13 | AA | accounts | Accounts with accounts type full | |
| 2024-08-01 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-06-18 | CH01 | officers | Change person director company with change date | |
| 2023-11-10 | CH01 | officers | Change person director company with change date | |
| 2023-09-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-06 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-29 | AA | accounts | Accounts with accounts type small | |
| 2023-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-04 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+355.9%
£1,877,000 £8,557,000
-
Cash
—
Not reported
-
Net assets
+10.6%
£13,861,000 £15,324,000
-
Employees
0%
2 2
-
Operating profit
+220.2%
£609,000 £1,950,000
-
Profit before tax
+45.2%
£9,609,000 £13,950,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers